Knockdown of METTL14 suppresses the malignant progression of non‑small cell lung cancer by reducing Twist expression
Cited by 24
Related Papers
Development of FAP-Targeted Chimeric Antigen Receptor NK-92 Cells for Non-Small Cell Lung Cancer
|Discovery Medicine|2023|25